The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aegerion Pharmaceuticals, Inc. | NOTE | 00767EAB8 | 17,243 | 24,200,000 | PRN | SOLE | 0 | 0 | 0 | ||
| Alimera Sciences, Inc | COM | 016259103 | 4,985 | 4,615,813 | SH | SOLE | 4,615,813 | 0 | 0 | ||
| Alere Inc. | COM | 01449J105 | 14,029 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| Aviragen Therapeutics, Inc. | COM | 053761102 | 380 | 309,278 | SH | SOLE | 309,278 | 0 | 0 | ||
| Biodelivery Sciences INTL | COM | 09060J106 | 4,551 | 2,600,711 | SH | SOLE | 2,600,711 | 0 | 0 | ||
| Cumberland Pharmaceuticals, Inc. | COM | 230770109 | 3,407 | 619,538 | SH | SOLE | 619,538 | 0 | 0 | ||
| Cardiome Pharma Corp | COM | 14159U301 | 8,718 | 3,158,816 | SH | SOLE | 3,158,816 | 0 | 0 | ||
| CTI Biopharma Corp | COM | 12648L106 | 1,067 | 2,617,136 | SH | SOLE | 2,617,136 | 0 | 0 | ||
| Cutera, Inc. | COM | 232109108 | 2,089 | 120,429 | SH | SOLE | 120,429 | 0 | 0 | ||
| Durect Corporation | COM | 266605104 | 2,918 | 2,177,791 | SH | SOLE | 2,177,791 | 0 | 0 | ||
| Enanta Pharmaceuticals | COM | 29251M106 | 7,769 | 231,913 | SH | SOLE | 231,913 | 0 | 0 | ||
| Flamel Technologies - SP ADR | SPONS ADR | 338488109 | 3,388 | 326,087 | SH | SOLE | 326,087 | 0 | 0 | ||
| Juniper Pharmaceuticals, Inc. | COM | 48203L107 | 1,279 | 228,392 | SH | SOLE | 228,392 | 0 | 0 | ||
| Mallinckrodt PLC | SHS | G5785G107 | 2,174 | 43,629 | SH | SOLE | 43,629 | 0 | 0 | ||
| Novelion Therapeutics, Inc. | COM | 67001K202 | 12,832 | 1,524,034 | SH | SOLE | 1,524,034 | 0 | 0 | ||
| Ophthotech Corp | COM | 683745103 | 11,075 | 2,292,900 | SH | SOLE | 2,292,900 | 0 | 0 | ||
| Recro Pharma, Inc. | COM | 75629F109 | 23,167 | 2,874,317 | SH | SOLE | 2,874,317 | 0 | 0 | ||
| Sciclone Pharmaceuticals, Inc. | COM | 80862K104 | 13,491 | 1,249,200 | SH | SOLE | 1,249,200 | 0 | 0 | ||
| Sucampo Pharmaceuticals - CL A | COM | 864909106 | 3,848 | 284,002 | SH | SOLE | 284,002 | 0 | 0 | ||
| Trinity Biotech PLC - SPON ADR | SPONS ADR | 896438306 | 3,018 | 436,066 | SH | SOLE | 436,066 | 0 | 0 | ||
| Vericel Corp | COM | 92346J108 | 5,651 | 1,883,800 | SH | SOLE | 1,883,800 | 0 | 0 | ||
| Veracyte, Inc. | COM | 92337F107 | 7,512 | 970,500 | SH | SOLE | 970,500 | 0 | 0 | ||
| Viveve Medical, Inc | COM | 92852W204 | 13,297 | 2,599,711 | SH | SOLE | 2,599,711 | 0 | 0 | ||